The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Meisner Derek M since 2020.
This trader's CIK number is 1752461.
At the time of last reporting, Meisner Derek M was the Chief Legal Officer & Corp Sec of Acumen Pharmaceuticals, Inc.. (stock ticker symbol ABOS).
Also see all insider trading activities at Acumen Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ABOS | 0 | $0 | 11,122 | $20,508 | 0 | $0 |
| 2024 | ABOS | 0 | $0 | 8,933 | $31,051 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | XFOR | 0 | $0 | 16,666 | $0 | 0 | $0 |
| 2021 | XFOR | 0 | $0 | 16,664 | $104,316 | 0 | $0 |
| 2020 | XFOR | 0 | $0 | 8,334 | $67,088 | 0 | $0 |
1. Acumen Pharmaceuticals, Inc. (ABOS)
2. X4 Pharmaceuticals, Inc (XFOR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-03 | ABOS | Sale | 11,122 | 1.84 | 20,508 |
| 2024-01-19 | ABOS | Sale | 8,933 | 3.48 | 31,051 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-08-17 | XFOR | Sale | 8,334 | .00 | 0 |
| 2022-06-24 | XFOR | Sale | 4,166 | .00 | 0 |
| 2022-06-16 | XFOR | Sale | 4,166 | .00 | 0 |
| 2021-08-17 | XFOR | Sale | 8,332 | 5.10 | 42,493 |
| 2021-06-24 | XFOR | Sale | 4,166 | 7.00 | 29,162 |
| 2021-06-15 | XFOR | Sale | 4,166 | 7.84 | 32,661 |
| 2020-09-09 | XFOR | Sale | 8,334 | 8.05 | 67,088 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Meisner Derek M (Chief Legal Officer & Corp Sec of Acumen Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.